Withholding Data That PTAB Would Deem Relevant to Patentability Supports Adverse Judgment in an IPR

July 19, 2023

Reading Time : 2 min

The Patent Trial and Appeal Board (PTAB) granted Petitioner’s motions to sanction Patent Owner for failure to meet its duty of candor and fair dealing in five related inter partes review  proceedings. The PTAB found that Patent Owner had improperly withheld the results of scientific testing that was material to the challenged patent claims.

The challenged patents relate to methods and compositions for killing pathogens and isolating populations of nucleic acids from biological samples. In its decisions to institute inter partes review, the PTAB rejected what it considered Patent Owner’s overly narrow construction of the terms “kill pathogens” and “not degrade nucleic acids,” construing each term to have its plain meaning. In the patent owner response and motion to amend, patent owner relied on test data and its proposed constructions to argue that the primary prior art reference did not anticipate the challenged claims.

Petitioner deposed Patent Owner’s testing witnesses, but Patent Owner instructed those witnesses not to answer questions about undisclosed testing on the basis of attorney work product protection. Petitioner disagreed with Patent Owner’s instruction that such underlying data were protected, and the parties held a conference call with the PTAB. The PTAB authorized additional briefing on the issue and ultimately ordered limited additional discovery, including production of any relevant inconsistent experimental results and additional deposition time for questioning about undisclosed testing. Petitioner discovered that Patent Owner had withheld data related to additional testing from the same time period that contradicted the testing on which Patent Owner had relied.

The PTAB issued a final written decision finding the challenged claims unpatentable and, on the same day, issued an order granting the sanction of judgment in the trial as to all challenged claims in the five IPRs. The PTAB explained that it was improper for Patent Owner to rely on its proposed (narrow) claim construction to limit the scope of its obligatory disclosures to the Office and Petitioner. Although the PTAB’s claim construction in its institution decision was preliminary, the PTAB clearly indicated the scope of what it deemed relevant to patentability in these proceedings. And ultimately, the PTAB found that the testing was relevant under either construction. By withholding these results until compelled by the Board, the Patent Owner had failed to comply with its duty of candor and good faith. However, the Board stopped short of ordering Patent Owner to compensate Petitioner, including by paying attorney fees. The Board reasoned that invalidation of the challenged claims would sufficiently deter such misconduct, while a monetary penalty would not.

On June 12, 2023, in each of the five IPR proceedings, the Director granted sua sponte review of both the Board’s final written decision and the order granting sanctions. As of the writing of this article, Director review remains pending.

Practice Tip: The duty of candor in a PTAB proceeding requires a party to disclose data that are material to patentability. At a minimum, this includes data that a party might consider not relevant under its own theory of the case, but that could be relevant under a broader theory of patentability, particularly where the PTAB’s institution decision expressly contemplates such a broader scope.

Spectrum Solutions LLC v. Longhorn Vaccines & Diagnostics, LLC, IPR2021-00847, Paper 107, IPR2021-00850, Paper 111, IPR2021-00854, Paper 110, IPR2021-00857, Paper 108, IPR2021-00860, Paper 109 (PTAB May 3, 2023).

Share This Insight

Previous Entries

IP Newsflash

April 1, 2025

The District of Delaware recently denied in part a motion to compel production of documents and testimony between a patentee and potential investors, valuation firms and an international bank based on the common interest exception. In so doing, the court reaffirmed that disclosure of privileged information to third parties will generally waive privilege unless it can be shown that the parties’ interests are identical and the communications are legal, not solely commercial.

...

Read More

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.